GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
-0.37%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.43B
AUM Growth
+$1.43B
(-0.86%)
Cap. Flow
-$2.36M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
31.81%
Holding
213
New
9
Increased
91
Reduced
53
Closed
8
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$2.66M |
| 2 |
AutoZone
AZO
|
$2.33M |
| 3 |
M&T Bank
MTB
|
$1.86M |
| 4 |
Hexcel
HXL
|
$1.7M |
| 5 |
RTX Corp
RTX
|
$935K |
Top Sells
| 1 |
GE Aerospace
GE
|
$7.41M |
| 2 |
eBay
EBAY
|
$1.75M |
| 3 |
Microsoft
MSFT
|
$1.69M |
| 4 |
PayPal
PYPL
|
$1.3M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.29M |
Sector Composition
| 1 | Technology | 29.17% |
| 2 | Healthcare | 14.99% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 12.54% |
| 5 | Consumer Staples | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Core S&P 500 ETF
IVV
$662B
| $970K | 0.07% |
2,250
+132
| +6% | +$56.9K |
|
102
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $960K | 0.07% |
15,694
+94
| +0.6% | +$5.75K |
|
103
Vanguard FTSE Pacific ETF
VPL
$7.72B
| $960K | 0.07% |
11,825
| – | – |
|
104
BioMarin Pharmaceuticals
BMRN
$11.2B
| $940K | 0.07% |
12,133
+399
| +3% | +$30.9K |
|
105
Jacobs Solutions
J
$17.5B
| $930K | 0.06% |
7,010
| – | – |
|
106
McDonald's
MCD
$224B
| $920K | 0.06% |
3,823
+421
| +12% | +$101K |
|
107
Philip Morris
PM
$260B
| $910K | 0.06% |
9,561
| – | – |
|
108
Incyte
INCY
$16.5B
| $900K | 0.06% |
13,140
+280
| +2% | +$19.2K |
|
109
AstraZeneca
AZN
$248B
| $860K | 0.06% |
+14,270
| New | +$860K |
|
110
West Pharmaceutical
WST
$17.8B
| $860K | 0.06% |
2,018
| – | – |
|
111
Comcast
CMCSA
$125B
| $840K | 0.06% |
15,103
+1,221
| +9% | +$67.9K |
|
112
H.B. Fuller
FUL
$3.29B
| $780K | 0.05% |
12,094
| – | – |
|
113
NextEra Energy, Inc.
NEE
$148B
| $770K | 0.05% |
9,780
+2,208
| +29% | +$174K |
|
114
Becton Dickinson
BDX
$55.3B
| $750K | 0.05% |
3,051
+11
| +0.4% | +$2.7K |
|
115
Vanguard Health Care ETF
VHT
$15.6B
| $750K | 0.05% |
3,045
| – | – |
|
116
Ionis Pharmaceuticals
IONS
$6.79B
| $730K | 0.05% |
21,691
+638
| +3% | +$21.5K |
|
117
Eli Lilly
LLY
$657B
| $710K | 0.05% |
3,071
| – | – |
|
118
AT&T
T
$209B
| $710K | 0.05% |
26,346
-1,231
| -4% | -$33.2K |
|
119
IBM
IBM
$227B
| $680K | 0.05% |
4,886
+200
| +4% | +$27.8K |
|
120
BP
BP
$90.8B
| $640K | 0.04% |
23,479
-846
| -3% | -$23.1K |
|
121
Novo Nordisk
NVO
$251B
| $640K | 0.04% |
6,717
+550
| +9% | +$52.4K |
|
122
Organon & Co
OGN
$2.45B
| $610K | 0.04% |
18,516
-11,269
| -38% | -$371K |
|
123
AbbVie
ABBV
$372B
| $600K | 0.04% |
5,583
+300
| +6% | +$32.2K |
|
124
Hubbell
HUBB
$22.9B
| $600K | 0.04% |
3,308
| – | – |
|
125
Cisco
CSCO
$274B
| $570K | 0.04% |
10,386
+2,849
| +38% | +$156K |
|